Kaken Pharmaceutical Co's total assets for Q4 2025 were ¥190.42B, a decrease of -1.55% from the previous quarter. KKPCF total liabilities were ¥37.78B for the fiscal quarter, a -1.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.